Effective July 5, 2022, Independence Administrators has updated its medical policy on proton beam radiation therapy.
The coverage position for postoperative prostate cancer has changed from Experimental/Investigational to Not Medically Necessary.
For more information, please view Medical Policy #09.00.49m: Proton Beam Radiation Therapy.